Onderneming Cryo-Cell International, Inc. Other OTC
Aandelen
CCEL
US2288951088
Gezondheidszorgvoorzieningen & -diensten
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Umbilical Cord Blood and Cord Tissue Stem Cell Service
98,3
%
| 30 | 98,1 % | 31 | 98,3 % | +3,44% |
Public Cord Blood Banking
1,5
%
| 0 | 1,5 % | 0 | 1,5 % | +4,23% |
PrepaCyte Cord Blood
0,2
%
| 0 | 0,3 % | 0 | 0,2 % | -36,10% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 30 | 100,0 % | 31 | 100,0 % | +3,32% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Mark Portnoy
CEO | Chief Executive Officer | 60 | 01-08-11 |
David Portnoy
CEO | Chief Executive Officer | 61 | 01-08-11 |
Jill Taymans
DFI | Director of Finance/CFO | 55 | 01-04-97 |
Joanne Kurtzberg
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-18 |
Oleg Mikulinsky
CTO | Chief Tech/Sci/R&D Officer | 50 | 05-03-12 |
Irene Smith
IRC | Investor Relations Contact | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Portnoy
CEO | Chief Executive Officer | 61 | 01-08-11 |
Mark Portnoy
CEO | Chief Executive Officer | 60 | 01-08-11 |
Harold Berger
BRD | Director/Board Member | 60 | 25-08-11 |
Daniel Mizrahi
BRD | Director/Board Member | 50 | 20-09-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 14 698 746 | 3 868 118 ( 26,32 %) | 6 594 269 ( 44,86 %) | 26,32 % |
Bedrijfsgegevens
Cryo-Cell International, Inc.
700 Brooker Creek Boulevard Suite 1800
34677, Oldsmar
+813 749 2100
http://www.cryo-cell.comSector
Verkoop per activiteit
Vaira. 1 jan. | Kapi. | |
---|---|---|
+13,70% | 80,61 mld. | |
-29,20% | 70,18 mld. | |
+9,72% | 29,08 mld. | |
-11,43% | 16,97 mld. | |
-0,43% | 16,96 mld. | |
-0,31% | 15,26 mld. | |
+3,42% | 12,41 mld. | |
-30,70% | 11,95 mld. | |
-6,75% | 11,93 mld. |